popEVE: diagnosing rare developmental disorders
Applied to about 30,000 patients with severe undiagnosed developmental disorders, it led to a diagnosis in about one-third of cases and identified variants in 123 previously unknown genes, 25 of which were independently confirmed by other labs. This is preliminary clinical use; further checks are needed before adoption, and the page gives no detailed metrics.
Technology: popEVE (variant-effect prediction model)
Publication: Peer-reviewed paper · Test context: prospective or independent check. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: prospective or independent check
- Tested: popEVE was tested on documented variants and case studies, and applied to about 30,000 undiagnosed patients, leading to a diagnosis in about one-third; 123 novel gene candidates were identified, and 25 were independently confirmed by other labs.
- Still unknown: The press article says popEVE will need further verification for safety and accuracy before wide clinical adoption, and gives no accuracy metrics; it is not yet in routine clinical use.
- AI role: A deep generative model extending EVE with a protein language model, producing a calibrated disease-likelihood score for each variant.
Evidence sources: https://hms.harvard.edu/news/new-artificial-intelligence-model-could-speed-rare-disease-diagnosis · https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=DOI:10.1038/s41588-025-02400-1&resultType=core&format=json
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: press release. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Editorial assessment: Impact 4/5 · Validation 4/5 · Novelty 4/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.